Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

Intellia Therapeutics

Status: Invitation-only

Conditions: Hereditary Angioedema

Study type: Observational

Funder types: Industry

Identifiers

NCT06262399

ITL-2002-CL-999

2022-003778-22 (EudraCT Number)

Details and patient eligibility

About

This is a follow-up study of subjects who received NTLA-2002 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.

Enrollment: 100 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. A subject has completed or discontinued from an Intellia-sponsored or -supported treatment protocol in which a complete or partial dose of NTLA-2002 was received.
2. A subject has provided informed consent for the LTFU study.
3. A subject is willing to attend study visits, complete protocol-required follow-up schedule, and comply with the study requirements.

Exclusion criteria

None